
Dermatology spinoff Dermavon files for IPO, with vitiligo drug as standout bet
More than 40 years ago, when Michael Jackson moonwalked into global stardom, his shifting skin tone brought mainstream attention to a little-known condition: vitiligo. Today, more than ten million people in China live with vitiligo, yet effective …